Quiz Maker LogoMake your own QuizCopy & Edit
Make your own quizManage my QuizzesPlans / FeaturesGuides and HelpContactPrivacy & Security

Molecular Pathology and Targeted Therapy Quiz

In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?
HRD status
Response to platinum-based therapy
Previous Platinum-free interval
For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?
15%
25%
50%
Which is the molecular type of endometrial carcinoma, most likely associated with good prognosis?
P53 abnormal
Non specific molecular profile
Mismatch Repair Deficient
Pole mutated
{"name":"Molecular Pathology and Targeted Therapy Quiz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?, For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?, Please enter your email address","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

More Quizzes

USMLE pediatric diagnosis
2001000
VRD | Chapter 3 - Quiz
6324
Apollo Space Program
25120
Copy Righ
1050
Let's test our knowledge
13610
Activity on High Heels
11617
Beni ne kadar iyi tanıyorsun
630
Hvaða tónlistartímabil ert þú?
840
Gram Stain
1475
How Much of a fan are you of Original 151
520
Explora la Cosmovisión
1267
AstrZt quiz
9424
Quiz Maker Logo Make your own Quiz
Powered by: Quiz Maker